Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Edgewise Therapeutics, Inc. (EWTX) had Free Cash Flow of $-83.11M for the most recently reported fiscal quarter, ending 2024-09-30.
| Income Statement Financials | |
-- |
|
$-34.13M |
|
-- |
|
-- |
|
$40.43M |
|
$-40.43M |
|
$6.30M |
|
$-34.13M |
|
$-34.13M |
|
$-34.13M |
|
$-34.13M |
|
$-34.13M |
|
$-34.13M |
|
$-40.43M |
|
$-43.07M |
|
93.81M |
|
93.81M |
|
$-0.36 |
|
$-0.36 |
|
| Balance Sheet Financials | |
$499.44M |
|
$9.97M |
|
$11.85M |
|
$511.28M |
|
$18.96M |
|
-- |
|
$3.45M |
|
$22.41M |
|
$488.88M |
|
$488.88M |
|
$488.88M |
|
94.41M |
|
| Cash Flow Statement Financials | |
$-82.07M |
|
$-205.58M |
|
$246.36M |
|
$86.10M |
|
$44.81M |
|
$-41.29M |
|
$16.98M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
26.35 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Free Cash Flow |
$-83.11M |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-6.98% |
|
-6.98% |
|
-6.68% |
|
-6.98% |
|
$5.18 |
|
$-0.89 |
|
$-0.87 |
|